ELN and cancer: Analysis by cancer subtypes showed NE-degraded elastin levels were 607% higher in squamous cell carcinoma (14.6 nM), 481% higher in adenocarcinoma (12.0 nM) and 402% higher in small cell lung cancer (10.3 nM) than in healthy matched controls.